Ticker

Cannara Releases Q2 FY26 Results: $27.2M revenue, 43% GM, $6.0M Adj. EBITDA, OCF $2.9M; 4.4% national share, #1 Québec; Valleyfield expansion progressing.

Vancouver, British Columbia--(Newsfile Corp. - March 19, 2026) - Cannara Biotech Inc. (TSX: LOVE) (OTCQX: LOVFF) (FSE: 8CB0) is a vertically integrated producer of affordable premium-grade cannabis and cannabis-derivative products for the Canadian market. The company recently uplisted to the Toronto Stock Exchange as it continues to build on its position as one of Canada's fastest-growing cannabis companies.

Toronto, Ontario--(Newsfile Corp. - March 17, 2026) - Donald Olds, Lead Director and Chairman of the Audit and Governance Committee, Cannara Biotech Inc. ("Cannara" or the "Company") (TSX: LOVE), together with members of the Company's leadership team, including Founder and CEO Zohar Krivorot, and invited business guests, joined Omar Khafagy, Head, Client Success, Toronto Stock Exchange ("TSX"), to open the market…